Knowledge Center

RH Raises Third Quarter and Annual Revenue Guidance

On November 15, RH announced its updated guidance for both the third quarter of 2017 and the full year. Third quarter revenue is expected to be around $592.5 million, which marks an 8% increase over the previous year despite reduced revenue due to Hurricanes Harvey and Irma. Third quarter EPS estimates are between $1.02 and […]

Read more...

Collegium Receives FDA Approval for Xtampza® ER

On November 7, Collegium Pharamceutical, Inc. (COLL) announced FDA approval of its supplemental new drug application for Xtampza® ER. The drug is an abuse-deterrent, extended-release opiod, for severe pain management needing daily, long-term relief. This is an important advance considering the opiod addiction epidemic in the United States. Xtampza® ER is the only single-agent oxycodone with the […]

Read more...

Promising Clinical Trial Results From Flex Pharma

On November 6, Flex Pharma Inc. (FLKS) reported positive stage 2 clinical trial results for a new drug to treat cramps and spasticity associated with a variety of neurological disorders. Positive topline data for FLX-787 indicates that significant improvement of pain and cramping is possible for those suffering from multiple sclerosis (MS), amyotrophic lateral sclerosis […]

Read more...

October 2017 Scorecard

The Oct 2017 scorecard for the signals generated from Sonal can be downloaded here. The results are summarized in this table: Scorecard Total Repurchases M&A Guidance Contracts Clinical Trials Correct – Prev Close to Next Close 59% 57% 81% 68% 46% 59% Correct – Prev Close to Next Session Peak 87% 90% 94% 85% 85% […]

Read more...

Care.com Beats Third-Quarter Earnings Estimates

Care.com (CRCM) announced its third-quarter earnings on the morning of November 2. The company reported quarterly EPS of $0.18 compared to analyst estimates of $0.08. Business revenue was also up 9.1% over the previous year. Care.com is an online marketplace for finding and managing family care needs.   Sonal caught the news and issued an […]

Read more...

Kirkland Lake Gold Reports Quarterly Earnings and Updates Annual Guidance

On November 2, Kirkland Lake Gold Ltd. (KL) reported third-quarter earnings. Although its EPS of $0.20 fell short of the analyst consensus average of $0.22, the company increased its earnings expectations for the year. The company’s targeted annual production rose to between 580,000 and 595,000 ounces. In addition, the quarterly dividend increased from $0.01 per […]

Read more...

KBR Awarded Engineering Support Service Contract

On November 2, KBR, Inc. (KBR) announced that the company was awarded a new contract to provide engineering support services for Abu Dhabi Gas (Al Hosn Gas). KBR will provide equipment, personnel, and technical support for facilities in the United Arab Emirates. KBR provides global professional and technical support for government and hydrocarbon services industries. […]

Read more...

AbbVie Reports Promising Phase 3 Clinical Trial Results

AbbVie (ABBV), in cooperation with Neurocrine Biosciences, Inc. (NBIX), announced detailed results from two phase 3 clinical trial extension studies on November 1. The studies were analyzing the long-term efficacy and safety of Elagolix, a drug for the managing the pain associated with endometriosis. The results showed no increased safety concern after twelve months along […]

Read more...

FICO Announces Stock Repurchase Program

The FICO Corporation (FICO), also known as the Fair Isaac Corporation, announced a new stock repurchase program on November 1. This new program follows the conclusion of its previous stock repurchase program that was effective from July 2016 through October 2017. In the new program, the Board of Directors authorized the repurchase of up to […]

Read more...